CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 18 enrolled
Drug / intervention
Levocetirizine Oral Tablet +2 moredrug
Likely dose
Fexofenadine 60 Mg Oral Tabletfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01586091
NCT01586091Phase 4Completed
CompareCT.gov

Comparison of Efficacy and Consistency of Action of Levocetirizine 5 mg Once Daily With Fexofenadine 60 mg Twice Daily in the Histamine Induced Wheal, Flare and Itch Response

Charite University, Berlin, Germany·interventional·Posted Apr 26, 2012·Updated Oct 4, 2019

In Brief

A Phase 4 clinical trial evaluating Levocetirizine Oral Tablet, Fexofenadine 60 Mg Oral Tablet, and 1 other intervention for Pruritus and 2 related conditions. Completed, enrolled 18 participants across 1 site.

Detailed Summary

This Study is to comparison of Efficacy and Consistency of Action of Levocetirizine 5 mg once daily with Fexofenadine 60 mg twice daily in the histamine induced wheal, flare and itch Response.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPruritus, Chronic Urticaria, Allergic Rhinitis
CountriesGermany
Collaborators--

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 26, 2012
Enrollment StartFeb 1, 2011
Primary CompletionNov 1, 2011
Study CompletionFeb 1, 2012
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 14.2 years ago

Interventions

Levocetirizine Oral Tabletdrug

Fexofenadine 60 Mg Oral Tabletdrug

Placebo Oral Tabletdrug